Cite

HARVARD Citation

    Abdelmoula, A. et al. (n.d.). P494 Impact of early optimization of ustekinumab on mid-term targets in severe Crohn's disease: THE MUST study. Journal of Crohn's and colitis. p. i625. [Online]. 
  
Back to record